Rostislav Vyzula

5.1k total citations · 1 hit paper
144 papers, 4.1k citations indexed

About

Rostislav Vyzula is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Rostislav Vyzula has authored 144 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Oncology, 53 papers in Molecular Biology and 51 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Rostislav Vyzula's work include MicroRNA in disease regulation (29 papers), Cancer-related molecular mechanisms research (26 papers) and Circular RNAs in diseases (25 papers). Rostislav Vyzula is often cited by papers focused on MicroRNA in disease regulation (29 papers), Cancer-related molecular mechanisms research (26 papers) and Circular RNAs in diseases (25 papers). Rostislav Vyzula collaborates with scholars based in Czechia, United States and United Kingdom. Rostislav Vyzula's co-authors include Ondřej Slabý, Marek Svoboda, Pavel Fabián, Lenka Radová, Jaroslav Michálek, Alexandr Poprach, Rudolf Nenutil, Radek Lakomý, Dana Knoflíčková and Tamara Šmerdová and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Rostislav Vyzula

134 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal Cancer

2007 589 citations Ondřej Slabý, Marek Svoboda et al. profile →

Peers

Rostislav Vyzula

ONCOL

PRM

SURGE

Seema Sethi United States

Seok Yun Kang South Korea

Akbar Shah Hussainy Pakistan

Li‐E Wang United States

Lin Xia China

Jorge Oliveira Portugal

José Alejandro Pérez Fidalgo Spain

Ayumu Taguchi United States

Adam E. Frampton United Kingdom

Seema Sethi United States

Rostislav Vyzula

1.9k ×0.6

1.2k ×0.5

957 ×1.3

ONCOL

614 ×0.9

PRM

271 ×1.0

SURGE

Citations per year, relative to Rostislav Vyzula Rostislav Vyzula (= 1×) peers Seema Sethi

Countries citing papers authored by Rostislav Vyzula

Since Specialization

Citations

This map shows the geographic impact of Rostislav Vyzula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rostislav Vyzula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rostislav Vyzula more than expected).

Fields of papers citing papers by Rostislav Vyzula

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rostislav Vyzula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rostislav Vyzula. The network helps show where Rostislav Vyzula may publish in the future.

Co-authorship network of co-authors of Rostislav Vyzula

This figure shows the co-authorship network connecting the top 25 collaborators of Rostislav Vyzula. A scholar is included among the top collaborators of Rostislav Vyzula based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rostislav Vyzula. Rostislav Vyzula is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Selingerová, Iveta, Radek Lakomý, Alexandr Poprach, et al.. (2024). Early changes of peripheral circulating immune subsets induced by PD-1 inhibitors in patients with advanced malignant melanoma and non-small cell lung cancer. BMC Cancer. 24(1). 1590–1590. 1 indexed citations

Sláma, Ondřej, et al.. (2020). Effects of Early and Systematic Integration of Specialist Palliative Care in Patients with Advanced Cancer: Randomized Controlled Trial PALINT. Journal of Palliative Medicine. 23(12). 1586–1593. 19 indexed citations

Büchler, Tomáš, Alexandr Poprach, Zbyněk Bortlíček, et al.. (2017). Outcomes of Patients With Long-Term Treatment Response to Vascular Endothelial Growth Factor-Targeted Therapy for Metastatic Renal Cell Cancer. Clinical Genitourinary Cancer. 15(6). e1047–e1053. 8 indexed citations

Lakomý, Radek, Alexandr Poprach, Zbyněk Bortlíček, et al.. (2017). Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry. BMC Cancer. 17(1). 880–880. 9 indexed citations

Poprach, Alexandr, Radek Lakomý, Zbyněk Bortlíček, et al.. (2016). Efficacy of Sunitinib in Elderly Patients with Metastatic Renal Cell Carcinoma: Data from Real-World Clinical Practice. Drugs & Aging. 33(9). 655–663. 15 indexed citations

Poprach, Alexandr, Zbyněk Bortlíček, Bohuslav Melichar, et al.. (2015). Efficacy of sunitinib in patients with metastatic or unresectable renal cell carcinoma and renal insufficiency. European Journal of Cancer. 51(4). 507–513. 10 indexed citations

Kocáková, Ilona, Ivo Kocák, Andrea Jurečková, et al.. (2015). Long term experience of patients with unresectable or metastatic KIT positive gastrointestinal stromal tumours. Bratislavské lekárske listy/Bratislava medical journal. 116(4). 218–221. 2 indexed citations

Obermannová, Radka, Ladislav Dušek, Jiří Jarkovský, et al.. (2015). Time-course pattern of blood 25-hydroxycholecalciferol is a significant predictor of survival outcome in metastatic colorectal cancer: a clinical practice-based study. Neoplasma. 62(6). 958–965. 7 indexed citations

Kubáčková, Kateřina, Zbyněk Bortlíček, Tomáš Pavlík, et al.. (2014). Prognostic factors in renal cell carcinoma patients treated with sorafenib: results from the Czech registry. Targeted Oncology. 10(3). 385–392. 6 indexed citations

10.

Büchler, Tomáš, Zbyněk Bortlíček, Alexandr Poprach, et al.. (2014). Efficacy of everolimus in second- and third-line therapy for metastatic renal cell carcinoma: A registry-based analysis. Urologic Oncology Seminars and Original Investigations. 32(5). 569–575. 12 indexed citations

11.

Dušek, Ladislav, Jan Mužı́k, Tomáš Pavlík, et al.. (2014). Cancer Incidence and Mortality in the Czech Republic. Klinicka onkologie. 27(6). 406–423. 38 indexed citations

12.

Hrstka, Roman, et al.. (2014). Second Primary Cancers – Causes, Incidence and the Future. Klinicka onkologie. 27(1). 11–17. 22 indexed citations

13.

Lakomý, Radek, Pavel Fadrus, Pavel Šlampa, et al.. (2011). Výsledky multimodální léčby glioblastoma multiforme:konsekutivní série 86 pacientů diagnostikovaných v letech2003–2009. Klinicka onkologie. 24(2). 1 indexed citations

14.

Dušek, Ladislav, Jitka Abrahámová, Jan Mužı́k, et al.. (2009). Populační odhady počtu nemocných s kolorektálním karcinomem -jeden z nástrojů včasné diagnostiky časných stadií a rekurenceonemocnění. 5. 1 indexed citations

15.

Dušek, Ladislav, et al.. (2008). Multivariate analysis of risk factors for testicular cancer: a hospital-based case-control study in the Czech Republic.. PubMed. 55(4). 356–68. 22 indexed citations

16.

Petráková, Katarína, Rudolf Nenutil, Pavel Fabián, et al.. (2008). [Factors predicting failure of adjuvant hormonotherapy of breast carcinoma. A study in tamoxifen treated patients].. PubMed. 21(5). 303–8. 1 indexed citations

17.

Slabý, Ondřej, Roman Hrstka, Lenka Zdražilová Dubská, et al.. (2008). Significance of microRNA-21 in colorectal cancer pathogenesis.. FEBS Journal. 275. 465–465. 1 indexed citations

18.

Svoboda, Marek, Pavel Fabián, Markéta Palácová, et al.. (2007). Brain metastases in breast cancer: a retrospective cohort studyof 187 patients and prognostic markers determination.. Breast Cancer Research and Treatment. 106. 1 indexed citations

19.

Dušek, Ladislav, et al.. (2005). The National Web Portal for Cancer Epidemiology in the Czech Republic.. EnviroInfo. 434–439. 1 indexed citations

20.

Wood, Patricia A. & Rostislav Vyzula. (1993). Circadian Hematopoietic Growth Factor Chronotherapy. 3(3). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact